Algernon Pharmaceuticals Inc.
Algernon Pharmaceuticals Inc. (AGNPF) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001642178 · AGNPF · OTC · as of Jun 15, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001642178 · Updated hourly · Not investment advice
SEC Filing History
No SEC filings found.
View directly on SEC EDGAR →About SEC Filings & 10-K Annual Reports
Algernon Pharmaceuticals Inc. (OTC: AGNPF) has submitted 0 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001642178, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Algernon Pharmaceuticals Inc.'s most comprehensive regulatory disclosure. The most recent Algernon Pharmaceuticals Inc. 10-K was filed on — for fiscal year ending —. Historical AGNPF 10-K annual reports are available from 2016 through —.
Investors researching Algernon Pharmaceuticals Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
AGNPF SEC Filings · 8 questionsAlgernon Pharmaceuticals Inc. (AGNPF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 0 filings and access original documents at no cost. Algernon Pharmaceuticals Inc.'s CIK is 0001642178.